These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1648350

  • 1. Inhibition of the specific binding of human lactotransferrin to human peripheral-blood phytohaemagglutinin-stimulated lymphocytes by fluorescein labelling and location of the binding site.
    Legrand D, Mazurier J, Maes P, Rochard E, Montreuil J, Spik G.
    Biochem J; 1991 Jun 15; 276 ( Pt 3)(Pt 3):733-8. PubMed ID: 1648350
    [Abstract] [Full Text] [Related]

  • 2. Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor lie in two loop-containing regions of the N-terminal domain I of human lactotransferrin.
    Legrand D, Mazurier J, Elass A, Rochard E, Vergoten G, Maes P, Montreuil J, Spik G.
    Biochemistry; 1992 Sep 29; 31(38):9243-51. PubMed ID: 1327110
    [Abstract] [Full Text] [Related]

  • 3. Study on the binding of lactotransferrin (lactoferrin) to human PHA-activated lymphocytes and non-activated platelets. Localisation and description of the receptor-binding site.
    Mazurier J, Legrand D, Leveugle B, Rochard E, Montreuil J, Spik G.
    Adv Exp Med Biol; 1994 Sep 29; 357():111-9. PubMed ID: 7762422
    [Abstract] [Full Text] [Related]

  • 4. The N-terminal domain I of human lactotransferrin binds specifically to phytohemagglutinin-stimulated peripheral blood human lymphocyte receptors.
    Rochard E, Legrand D, Mazurier J, Montreuil J, Spik G.
    FEBS Lett; 1989 Sep 11; 255(1):201-4. PubMed ID: 2551729
    [Abstract] [Full Text] [Related]

  • 5. Analysis of insulin receptors on heterogeneous eukaryotic cell populations with fluorochrome-conjugated insulin and fluorescence-activated cell sorter. Advantages and limitations to the 125I-labelled insulin methodology.
    Due C, Linnet K, Langeland Johansen N, Olsson L.
    Diabetologia; 1985 Oct 11; 28(10):749-55. PubMed ID: 2415418
    [Abstract] [Full Text] [Related]

  • 6. Lactotransferrin binding to its platelet receptor inhibits platelet aggregation.
    Leveugle B, Mazurier J, Legrand D, Mazurier C, Montreuil J, Spik G.
    Eur J Biochem; 1993 May 01; 213(3):1205-11. PubMed ID: 8389297
    [Abstract] [Full Text] [Related]

  • 7. Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography.
    Mazurier J, Legrand D, Hu WL, Montreuil J, Spik G.
    Eur J Biochem; 1989 Feb 01; 179(2):481-7. PubMed ID: 2537213
    [Abstract] [Full Text] [Related]

  • 8. Evidence for interactions between the 30 kDa N- and 50 kDa C-terminal tryptic fragments of human lactotransferrin.
    Legrand D, Mazurier J, Aubert JP, Loucheux-Lefebvre MH, Montreuil J, Spik G.
    Biochem J; 1986 Jun 15; 236(3):839-44. PubMed ID: 3790094
    [Abstract] [Full Text] [Related]

  • 9. Biological activity of a fluorescein human growth hormone derivative prepared by specific covalent labeling of lysine-70.
    Sakal E, Gertler A, Shechter Y.
    Biochemistry; 1991 Sep 10; 30(36):8899-904. PubMed ID: 1909577
    [Abstract] [Full Text] [Related]

  • 10. Labelling of histone H5 and its interaction with DNA. 1. Histone H5 labelling with fluorescein isothiocyanate.
    Favazza M, Lerho M, Houssier C.
    J Biomol Struct Dyn; 1990 Jun 10; 7(6):1291-300. PubMed ID: 2114121
    [Abstract] [Full Text] [Related]

  • 11. The fluorescein isothiocyanate-binding site of the plasma-membrane H+-ATPase of Neurospora crassa.
    Pardo JP, Slayman CW.
    J Biol Chem; 1988 Dec 15; 263(35):18664-8. PubMed ID: 2904434
    [Abstract] [Full Text] [Related]

  • 12. Characterization of two kinds of lactotransferrin (lactoferrin) receptors on different target cells.
    Spik G, Legrand D, Leveugle B, Mazurier J, Mikogami T, Montreuil J, Pierce A, Rochard E.
    Adv Exp Med Biol; 1994 Dec 15; 357():13-9. PubMed ID: 7762424
    [Abstract] [Full Text] [Related]

  • 13. Determination of the LDL receptor binding capacity of human lymphocytes by immunocytofluorimetric assay.
    Benhamamouch S, Kuznierz JP, Agnani G, Marzin D, Lecerf JM, Fruchart JC, Clavey V.
    Biochim Biophys Acta; 1989 Mar 14; 1002(1):45-53. PubMed ID: 2493806
    [Abstract] [Full Text] [Related]

  • 14. Fluorescein isothiocyanate specifically modifies lysine 338 of cytochrome P-450scc and inhibits adrenodoxin binding.
    Tuls J, Geren L, Millett F.
    J Biol Chem; 1989 Oct 05; 264(28):16421-5. PubMed ID: 2506177
    [Abstract] [Full Text] [Related]

  • 15. Reaction of fluorescein isothiocyanate with an ATP-binding site on the phosphorylase kinase alpha subunit.
    Zaman N, Varsányi M, Heilmeyer LM, Sotiroudis TG, Johnson CM, Crabb JW.
    Eur J Biochem; 1989 Jul 01; 182(3):577-84. PubMed ID: 2502392
    [Abstract] [Full Text] [Related]

  • 16. The appearance of fluorescein-labelled lymphocytes in lymph following in vitro or in vivo labelling: the route of lymphocyte recirculation through mesenteric lymph nodes.
    Chin GW, Cahill NP.
    Immunology; 1984 Jun 01; 52(2):341-7. PubMed ID: 6429037
    [Abstract] [Full Text] [Related]

  • 17. Modification of actin with fluorescein isothiocyanate.
    Burtnick LD.
    Biochim Biophys Acta; 1984 Nov 23; 791(1):57-62. PubMed ID: 6437449
    [Abstract] [Full Text] [Related]

  • 18. Site-specific fluorescein-labeled cobra alpha-toxin. Biochemical and spectroscopic characterization.
    Johnson DA, Taylor P.
    J Biol Chem; 1982 May 25; 257(10):5632-6. PubMed ID: 6802819
    [Abstract] [Full Text] [Related]

  • 19. Demonstration of specific receptors for fluoresceinated casein on human neutrophils and monocytes using flow cytometry.
    Lewis SL, Van Epps DE.
    Inflammation; 1983 Dec 25; 7(4):363-75. PubMed ID: 6317559
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.